92 related articles for article (PubMed ID: 2526491)
1. Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Lefer AM
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():321-6. PubMed ID: 2526491
[No Abstract] [Full Text] [Related]
2. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Bhat AM; Sacks H; Osborne JA; Lefer AM
Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
[TBL] [Abstract][Full Text] [Related]
3. Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
Viehman GE; Ma XL; Lefer AM
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):651-6. PubMed ID: 1966110
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
Osborne JA; Lefer AM
Am J Physiol; 1988 Aug; 255(2 Pt 2):H318-24. PubMed ID: 2970233
[TBL] [Abstract][Full Text] [Related]
5. Preservation of ischemic myocardium by pinane thromboxane A2.
Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
[TBL] [Abstract][Full Text] [Related]
6. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
Bitterman H; Yanagisawa A; Lefer AM
Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of new powerful thromboxane antagonists (3-alkylamino pinane derivatives).
Katsura M; Miyamoto T; Hamanaka N; Kondo K; Terada T; Ohgaki Y; Kawasaki A; Tsuboshima M
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():351-7. PubMed ID: 6221545
[No Abstract] [Full Text] [Related]
8. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
Schumacher WA; Heran CL
J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
[TBL] [Abstract][Full Text] [Related]
9. Role of the prostaglandin-thromboxane system in vascular homeostasis during shock.
Lefer AM
Circ Shock; 1979; 6(4):297-303. PubMed ID: 394877
[No Abstract] [Full Text] [Related]
10. Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders.
Lefer AM
Prog Clin Biol Res; 1988; 264():101-14. PubMed ID: 2837782
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
Tsao PS; Lefer AM
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Kawakage M; Shirakura S; Karasawa A; Takeda M; Miki I; Ishii A; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1246-50. PubMed ID: 1815524
[TBL] [Abstract][Full Text] [Related]
13. Effect of Bay U 3405, a new thromboxane antagonist, on collagen-induced thromboembolism in rabbits.
Seuter F; Perzborn E; Fiedler VB
Stroke; 1990 Dec; 21(12 Suppl):IV146-8. PubMed ID: 2260139
[TBL] [Abstract][Full Text] [Related]
14. [Function of prostaglandins in platelet aggregation].
Sun QW
Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620
[No Abstract] [Full Text] [Related]
15. Resting myocardial ischemia after intravenous infusion of BM 13.177 (sulotroban), a thromboxane receptor antagonist.
Terres W; Kupper W; Hamm CW; Bleifeld W
Thromb Res; 1987 Dec; 48(5):577-83. PubMed ID: 2964739
[No Abstract] [Full Text] [Related]
16. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
Löbel P; Schrör E; Schrör K
Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
[TBL] [Abstract][Full Text] [Related]
17. [Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
Okuma M
Nihon Rinsho; 1978 Dec; 36(12):3830-5. PubMed ID: 372621
[No Abstract] [Full Text] [Related]
18. The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
Thiemermann C; Ney P; Schrör K
Eur J Pharmacol; 1988 Oct; 155(1-2):57-67. PubMed ID: 2977337
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Aoki N; Lefer AM
Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
[TBL] [Abstract][Full Text] [Related]
20. Effect of BAY U 3405, a new thromboxane antagonist, on arachidonic acid induced thromboembolism.
Seuter F; Perzborn E; Fiedler VB
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():355-8. PubMed ID: 1825569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
